TOPICS: COVID-19

 

Mozambique hasn’t yet had a case of COVID-19 in the country: how prepared are you?

We are closely monitoring the situation in Italy, South Korea, China and other countries where the outbreak is currently hitting the hardest. Even though we haven’t yet had a case of COVID-19 in Mozambique, we want to be ready if it does eventually reach our country.

This is a very serious public health concern for Mozambique authorities. The outbreak is currently mainly in countries that have strong health systems and the resources to respond, as well as the means to identify cases and treat people infected. One of our greatest challenges will be ensuring the protocols and tools are in place here to help us contain and manage it if the virus does reach here. 

What are you doing in terms of public health measures to prevent the pandemic in Mozambique? 

All points of entry to the country are now operating a screening process. Additional screening is given to travelers from affected areas. It is important to note that Mozambique and other countries in Africa have had to deal with pandemics for as long as I can remember, and, while COVID-19 is extremely worrying, we cannot lose sight of other issues in our country, such as cholera, pneumococcal disease and measles. It is absolutely essential therefore that we ensure that routine immunisation services continue and that people in Mozambique, and other countries, are protected from diseases that can be prevented by vaccines.  

What, in your opinion, would be the biggest challenges for Mozambique to address the COVID-19 outbreak? 

Our overall response capacity is not the same as that of the countries in Europe, therefore one of the biggest challenges for Mozambique would be the capacity of our health systems to cope with the influx of sick people to hospitals and clinics. Not only that, but our health workers have demonstrated incredible heroism and resilience when addressing the cholera outbreak following Cyclone Idai in March last year, and they will be the first ones at risk of COVID-19 as frontline responders to the outbreak. We must keep that in mind. While the number of health workers has increased in Mozambique over the last decade, we will not be able to deliver treatment and services, should they be affected by the virus. 

Geography is also a challenge. There are communities that do not have access to a clinic or where the nearest health facility is 20km away. For these communities, even a small outbreak can have a devastating impact. People in these areas are usually the most vulnerable and so we must prioritise reaching them with support.  

How can the leaders of countries that are currently experiencing the pandemic help you prepare?

The biggest help we need, and what is already being done, is information sharing. This has been unprecedented; we are able to monitor the situation as it develops in countries in Europe and Asia. The hope is that if the outbreak hits Mozambique severely, there will already be clinical information on transmission and best treatment, which we can use here to contain the spread of the virus.

What can the global health community do to support countries like Mozambique in addressing the coronavirus outbreak should it severely hit countries in Africa?

If COVID-19 teaches us anything, it is that a major outbreak in a country with a weak health system can be a real disaster, and we must all work together to prevent the virus from spreading further. Countries like Mozambique do not have the same resources as wealthier countries in Europe and Asia to tackle the outbreak, therefore funding and technical support for the health systems strengthening from the global health community must continue.

Is there anything the countries hit hardest by coronavirus can learn from Mozambique, given your experience in combatting outbreaks?

When an outbreak hits, we must do everything possible to contain it – that should be our priority. However, we are a small country with a very stretched health system at the best of times. Often, we have to deal with more than one serious disease outbreak. Despite the challenges this presents, we have learned that we must find ways to continue to provide routine health services to the population, making sure that people get the necessary treatment and children are protected against vaccine-preventable diseases through immunisation. We know that should those services stop, we might be facing an even greater toll due to the collateral damage wrought on our already strained health infrastructure.

COVID-19 related

Investment in bedside oxygen production could make hospitals more resilient in the face of COVID-19.

Scientists around the world are working faster than ever to develop and produce vaccines that can stop the spread of COVID-19. Since the emergence of this novel coronavirus in December 2019, more than a dozen vaccines have started to be rolled…

Vaccines are one of our greatest success stories, but vaccination rates for many diseases have been stalling; this has been exacerbated with the disruption caused by Covid-19. Anna Mouser sets out the evidence on what works, and what doesn’t, for…

To reach zero-dose children in conflict states like South Sudan, social mobilisers like Nyok Daniel are crucial to winning the trust and support of local communities.

Climate change, changes in land use, recreational activities and the trade of infected animals could make this fatal disease more commonplace.

The impact of COVID-19 threatens to reverse hard-worn strides in global health. Without immediate investments, we will miss our chance to save lives and help countries recover from the pandemic and build the human capital needed for a resilient…

Although it is only natural and proper for governments to focus on vaccinating their citizens first, it is important not to lose sight of the big picture. The only way we can beat COVID-19 is to defeat it everywhere, and the best way to do that…

Trying to control a pandemic can feel like being in a warzone, yet even as we fight COVID-19 we still need to keep one eye on the future and potential emerging pandemics. Dr Velislava Petrova, senior manager in vaccine policy and investment at…

Distributing COVID-19 vaccines has been challenging, meaning in some cases vaccines are being delivered close to their expiration date; but the WHO is urging countries to hold on to the doses while it assesses whether shelf lives can be extended…

The signed advance purchase agreement (APA) is for up to 500 million doses of the COVID-19 vaccine manufactured by Moderna. Supply via the agreement will take place from the second half of 2021 through 2022, with options in place to address the…

Globally, antibiotic use in hospitals has surged since the start of the COVID-19 pandemic, and over-the-counter sales, legal in many countries, have soared. This is further fueling the global crisis of antimicrobial resistance, as bacteria evolve…

Subscribe to our newsletter